Congress extends grace period for drug-shortage compounding pharmacies

What it does

This bill amends federal pharmacy law to allow outsourcing facilities (specialized compounding pharmacies) to continue supplying drugs for 180 calendar days after a drug enters shortage, rather than stopping immediately. The change gives these facilities a defined grace period to help bridge supply gaps and reduce drug shortages affecting patients.

Why we flagged it

The bill's operative mechanism is a narrow regulatory amendment extending a grace period for compounding facilities during drug shortages. It is a targeted public-health measure, not a broad deregulation or industry carve-out.

What the text implies

• The 180-day tail period may create incentive for outsourcing facilities to delay reporting shortage resolution, though the bill does not explicitly address this.
• The amendment applies to both subsection (a)(2)(A)(ii) and (d)(2)(A) of 503B; without access to the full text of those provisions, the full scope of the change cannot be fully assessed, though the bill's stated purpose suggests both relate to shortage-period compounding authority.
• The bill does not specify what happens if a drug shortage is declared resolved before the 180 days elapse—whether the tail period is automatically terminated or continues to expiration.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Patients facing drug shortages benefit from a longer supply window; outsourcing facilities gain regulatory clarity and operational flexibility to help mitigate shortages. The 180-day tail period is a modest, time-limited extension that does not appear to weaken safety oversight—it simply delays the cutoff point at which compounding must cease.

Who stands to gain

• outsourcing facilities (compounding pharmacies)
• pharmaceutical supply chain intermediaries

Named in the bill

outsourcing facilities, Federal Food, Drug, and Cosmetic Act, Section 503B, FDA (implied regulatory authority)

Where it stands

• Feb 12, 2026 — Introduced · Congress.gov: “Introduced in House”
• Feb 12, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.